Step by Stepa HemeOncBuddy patient portal

Pazopanib

Illustration: Pazopanib

Say it: puh-ZOH-puh-nib · Brand names: Votrient

Pazopanib is a targeted pill that blocks several growth signals and cuts off the blood supply tumors need.

What it is

Tumors need new blood vessels to grow. Pazopanib blocks signals, such as VEGF, that tell new blood vessels to form. This can slow tumor growth.

Often used for

How you get it

It is a pill you take by mouth once a day on an empty stomach. Take it at least 1 hour before or 2 hours after a meal. People usually take it for as long as it works. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Pazopanib?
Pazopanib is a targeted pill that blocks several growth signals and cuts off the blood supply tumors need. Brand names: Votrient.
What is Pazopanib used for?
kidney cancer; soft tissue sarcoma after chemotherapy.
How is Pazopanib given?
It is a pill you take by mouth once a day on an empty stomach. Take it at least 1 hour before or 2 hours after a meal. People usually take it for as long as it works. Your schedule may be different.
What are the common side effects of Pazopanib?
Diarrhea. High blood pressure. Hair turning lighter or white. Nausea or vomiting. Feeling tired. Less appetite or changes in taste.
When should I call my care team while taking Pazopanib?
Yellow skin or eyes, dark urine, or pain on the right side of your belly; Bad headache, or blood pressure higher than your team told you to expect; Bleeding that will not stop, black or bloody stools, or coughing up blood; Chest pain, or numbness or weakness on one side, or trouble speaking; A fast, slow, or pounding heartbeat, or feeling like you might faint; New or worse cough, shortness of breath, or chest pain.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.